First in Human Study in Subjects With Obesity, But Otherwise Healthy
NCT06252220
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
139
Enrollment
INDUSTRY
Sponsor class
Conditions
Obesity
Interventions
DRUG:
DA-1726
DRUG:
Placebo to DA-1726
Sponsor
NeuroBo Pharmaceuticals Inc.